Back to Agenda
Session 3a: Change Management – From Insights Into Action
Session Chair(s)
Dyan Bryson
VP, Diversity Services, TOTAL Diversity Clinical Trial Management, United States
What does it take for a company to achieve change management on diversity and inclusion (D&I) efforts? What is the momentum needed within a company to take on D&I efforts? What tools and resources currently exist? How does one engage with the CEO and leadership on these efforts? These questions and more will be explored as you join experts who have tackled these challenges and will provide solutions that work towards change management best practices of D&I efforts, driving insights into action.
Learning Objective : - Understand the conscious decision making it takes for a company to pursue diversity in clinical trials
- Describe the steps it takes to truly put the patient at the center of the business
- Contribute to internal discussions to manage the challenges of enhancing diversity in clinical trials
- Understand that enhancing clinical trials and being patient centered are two inseparable concepts
Speaker(s)
Anthony Yanni, MD, MBA
SVP, Patient Centricity, Astellas, United States
Business Model Evolution – Putting the Patient at the Center
Jessica S. Scott, JD, MD
President, Legacy Health Strategies , United States
Getting it Done: Clinical Trial Diversity
Donna Schwarz
Founder, Schwarz Consultants, United States
Getting it Done: Clinical Trial Diversity
Adam Brown
Founder and CEO, Clinark, United States
Clinical Trial Diversity: The Supplier Perspective
Danielle Mitchell
CEO and Founder, Black Women in Clinical Research, United States
Clinical Trial Diversity: The Supplier Perspective
Marya Shegog, MPH
Health Equity and Diversity Coordinator, The Lazarus Project, United States
Clinical Trial Diversity: The Supplier Perspective
Douglas Noland, MBA
Head of Patient Partnerships, Executive Director, Astellas, United States
Business Model Evolution – Putting the Patient at the Center
Have an account?